ue. Tutogen utilizes
its proprietary Tutoplast Process(R) of tissue preservation and viral
inactivation to manufacture and deliver sterile bio-implants used in
spinal/trauma, urology, dental, ophthalmology, and general surgery
procedures. The Company's Tutoplast(R) products are sold and distributed
worldwide by Zimmer Spine and Zimmer Dental, subsidiaries of Zimmer
Holdings, Inc., Davol Inc., a subsidiary of C.R. Bard Inc., the Mentor
Corporation, Coloplast Corp., IOP, Inc. and through independent
distributors internationally. For more information, visit the Company's Web
site at
http://www.tutogen.com.
Forward-Looking Statement Disclaimer:
This press release contains "forward-looking statements" within the
meaning of the Private Securities Litigation Reform Act of 1995.
Forward-looking statements typically are identified by use of terms such as
"may," "will," "should," "plan," "expect," "anticipate," "estimate," and
similar words, although some forward-looking statements are expressed
differently. Forward-looking statements are based on management's current
expectations and are subject to certain risks and uncertainties, including
the likelihood of completing the merger with Regeneration Technologies,
Inc. that could cause actual results to differ materially from those set
forth or implied by forward-looking statements. These and other risks are
identified in the Company's filings with the Securities and Exchange
Commission, including the Company's Definitive Proxy Statement filed with
the Securities and Exchange Commission on January 23, 2008 and its Annual
Report on Form 10-K for the fiscal year ended September 30, 2007. All
information in this press release is as of the date hereof, and the Company
undertakes no duty to update this information unless required by law.
Important Additional Information and Where to Find It
The proposed merger will be submitted to the respective stockhold
'/>"/>
SOURCE Tutogen Medical, Inc. Copyright©2008 PR Newswire. All rights reserved | |
Page: 1 2 3 4 5 6 7 8 Related biology technology :1.
Tutogen Medical, Inc. to Present at the Roth Capital Partners 2007 New York Conference2.
Tutogen Medical, Inc. and Zimmer Holdings, Inc. Announce Agreement for International Distribution of Biological Products3.
Zimmer and Tutogen Announce Agreement for International Distribution of Biological Products4.
Tutogen Medical, Inc. to Report Fourth Quarter and Fiscal Year 2007 Financial Results5.
Tutogen Medical, Inc. Reports Year-End Fiscal 2007 Financial Results6.
Nonin Medical, Inc. Receives Frost & Sullivans 2007 Award for Product Differentiation Innovation7.
EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound8.
QMed, Inc. Reports July Medicare SNP Enrollments9.
Phlo Affiliate Reports Expanded Coverage to Oregon Border10.
Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results11.
Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007